AQR Capital Management’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.84M | Buy |
163,790
+4,851
| +3% | +$54.6K | ﹤0.01% | 1825 |
|
|
2025
Q1 | $906K | Buy |
158,939
+121,326
| +323% | +$692K | ﹤0.01% | 2088 |
|
|
2024
Q4 | $369K | Sell |
37,613
-2,818
| -7% | -$27.7K | ﹤0.01% | 2400 |
|
|
2024
Q3 | $330K | Sell |
40,431
-218,647
| -84% | -$1.78M | ﹤0.01% | 2357 |
|
|
2024
Q2 | $3.39M | Buy |
+259,078
| New | +$3.39M | 0.01% | 1212 |
|
|
2024
Q1 | – | Sell |
-980
| Closed | -$66.3K | – | 2436 |
|
|
2023
Q4 | $66.3K | Buy |
980
+393
| +67% | +$26.6K | ﹤0.01% | 2296 |
|
|
2023
Q3 | $42.4K | Buy |
+587
| New | +$42.4K | ﹤0.01% | 2291 |
|
|
2022
Q4 | – | Sell |
-15,310
| Closed | -$1.91M | – | 2216 |
|
|
2022
Q3 | $1.91M | Buy |
+15,310
| New | +$1.91M | ﹤0.01% | 1222 |
|